CSL’s Hemgenix receives MHRA authorisation
Treatment is the only single infusion gene therapy for the treatment of severe haemophilia B
Read More
Tag: CSL
CSL’s first gene therapy for haemophilia B approved
Boost for effected patients as HEMGENIX receives green light from European Commission
Read More
New flu vaccine approved for UK use
The Medicines and Healthcare products Regulatory Agency has cleared the adjuvanted trivalent influenza vaccine Fluad for use in people aged 65 years or older.
Read More
- Storm Therapeutics and AlidaBio launch collaboration to advance RNA‑targeting cancer therapies
- Excellence adventure
- MHRA approves Nucala for eosinophilic COPD in adults on triple therapy
- Bial launches new sublingual Parkinson’s treatment in UK
- Acesion Pharma launches phase 2 trial of AP31969 in atrial fibrillation
